Array

ß-Rezeptoren-Blocker/en: Unterschied zwischen den Versionen

(Auto-translated text.)
 
(Auto-translated text.)
 
Zeile 1: Zeile 1:
 
<languages />
 
<languages />
ß-Rezeptor-Antagonisten. Pharmaka mit hoher Affinität zu adrenergen ß-Rezeptoren, wodurch sie die physiologischen Mediatoren Adrenalin und Noradrenalin verdrängen können, ohne deren Wirkung auszuüben, im Unterschied zu wirksamen ß-Rezeptor-Agonisten. Man unterscheidet ß1-selektive Betablocker und nichtselektive Betablocker, die ß1- und ß2-Rezeptoren gleichermaßen beeinflussen.
+
ß-receptor antagonists. Pharmaceuticals having a high affinity for adrenergic ß-receptors, whereby they can displace the physiological mediators adrenaline and noradrenaline without exerting their effect, unlike effective ß-receptor agonists. A distinction is made between ß1-selective beta-blockers and non-selective beta-blockers, which influence ß1- and ß2-receptors equally.

Aktuelle Version vom 16. April 2019, 22:38 Uhr

ß-receptor antagonists. Pharmaceuticals having a high affinity for adrenergic ß-receptors, whereby they can displace the physiological mediators adrenaline and noradrenaline without exerting their effect, unlike effective ß-receptor agonists. A distinction is made between ß1-selective beta-blockers and non-selective beta-blockers, which influence ß1- and ß2-receptors equally.